Literature DB >> 2493427

Fulminant colitis and toxic megacolon.

S H Danovitch1.   

Abstract

Twenty-seven cases of fulminant colitis are reported. All had at least five of the seven criteria of severity. Four developed toxic megacolon. Sixty-three per cent failed to respond to parenteral steroids, parenteral nutrition, and vigorous resuscitation and required surgery. Two of the patients with megacolon perforated and died. Prompt attention to these patients and a willingness to rely on surgery are important approaches. The experience reported here reiterates that previously published.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2493427

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  5 in total

Review 1.  Current concept of pathophysiological understanding and natural course of ulcerative colitis.

Authors:  Martin H Holtmann; Peter R Galle
Journal:  Langenbecks Arch Surg       Date:  2004-02-04       Impact factor: 3.445

2.  Incidence, features, in-hospital outcomes and predictors of in-hospital mortality associated with toxic megacolon hospitalizations in the United States.

Authors:  Rajkumar Doshi; Jiten Desai; Yash Shah; Dean Decter; Shreyans Doshi
Journal:  Intern Emerg Med       Date:  2018-06-12       Impact factor: 3.397

3.  Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity.

Authors:  F Carbonnel; A Lavergne; M Lémann; A Bitoun; P Valleur; P Hautefeuille; A Galian; R Modigliani; J C Rambaud
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

Review 4.  A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease.

Authors:  Seyed Saeid Seyedian; Forogh Nokhostin; Mehrdad Dargahi Malamir
Journal:  J Med Life       Date:  2019 Apr-Jun

Review 5.  Toxic Megacolon: Background, Pathophysiology, Management Challenges and Solutions.

Authors:  Jiten Desai; Mohamed Elnaggar; Ahmed A Hanfy; Rajkumar Doshi
Journal:  Clin Exp Gastroenterol       Date:  2020-05-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.